Pacira BioSciences, Inc.
US ˙ NasdaqGS ˙ US6951271005

SecurityPCRX / Pacira BioSciences, Inc.
InstitutionFranklin Resources Inc
Latest Disclosed Ownership32,922 shares
Latest Disclosed Value $ 744,037
Franklin Resources Inc reports 2.77% decrease in ownership of PCRX / Pacira BioSciences, Inc.

On May 13, 2026 - Franklin Resources Inc filed a 13F-HR form disclosing ownership of 32,922 shares of Pacira BioSciences, Inc. (US:PCRX) valued at $744,037 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 33,860 shares of Pacira BioSciences, Inc.. This represents a change in shares of -2.77% during the quarter. The current value of the position is $734,819 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F PACIRA BIOSCIENCES COM 695127100 32,922 -938 -2.77 744 -15.07 0.0000
2026-02-11 2025-12-31 13F PACIRA BIOSCIENCES COM 695127100 33,860 846 2.56 876 3.06 0.0002
2025-11-13 2025-09-30 13F PACIRA BIOSCIENCES COM 695127100 33,014 1,954 6.29 851 14.56 0.0002
2025-08-12 2025-06-30 13F PACIRA BIOSCIENCES COM 695127100 31,060 2,949 10.49 742 6.30 0.0002
2025-05-13 2025-03-31 13F PACIRA BIOSCIENCES COM 695127100 28,111 28,111 699 0.0002
2024-11-27 2024-09-30 13F/A-1 PACIRA BIOSCIENCES COM 695127100 0 -9,258 -100.00 0 -100.00
2024-11-12 2024-09-30 13F PACIRA BIOSCIENCES COM 695127100 0 0
2024-08-14 2024-06-30 13F PACIRA BIOSCIENCES COM 695127100 9,258 9,258 265 0.0001
2024-02-09 2023-12-31 13F PACIRA BIOSCIENCES COM 695127100 0 -7,687 -100.00 0 -100.00
2023-11-13 2023-09-30 13F PACIRA BIOSCIENCES COM 695127100 7,687 7,687 236 0.0001
2023-02-10 2022-12-31 13F PACIRA BIOSCIENCES COM 695127100 0 -5,049 -100.00 0 -100.00
2022-11-14 2022-09-30 13F PACIRA BIOSCIENCES COM 695127100 5,049 190 3.91 269 -4.95 0.0001
2022-08-11 2022-06-30 13F PACIRA BIOSCIENCES COM 695127100 4,859 -271 -5.28 283 -27.81 0.0001
2022-05-13 2022-03-31 13F PACIRA BIOSCIENCES COM 695127100 5,130 962 23.08 392 56.18 0.0002
2022-02-11 2021-12-31 13F PACIRA BIOSCIENCES COM 695127100 4,168 98 2.41 251 10.09 0.0001
2021-11-12 2021-09-30 13F PACIRA BIOSCIENCES COM 695127100 4,070 4,070 228 0.0001
2016-05-10 2016-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 0 0 0 0.0000
2016-04-27 2015-12-31 13F/A-1 PACIRA PHARMACEUTICALS COM 695127100 0 0 0 0.0000
2015-11-10 2015-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 0 -19,336 -100.00 0 -100.00
2015-08-12 2015-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 19,336 697 3.74 1,367 -17.45 0.0006
2015-05-14 2015-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 18,639 2,030 12.22 1,656 12.42 0.0008
2015-02-10 2014-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 16,609 16,609 0.00 1,473 -93.59 0.0007
2014-11-12 2014-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 0 -17,245 -100.00 0 -100.00
2014-08-12 2014-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 17,245 -165,280 -90.55 1,584 -87.60 0.0007
2014-05-13 2014-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 182,525 10,800 6.29 12,775 29.41 0.0060
2014-02-12 2013-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 171,725 -463,095 -72.95 9,872 -67.66 0.0048
2013-11-14 2013-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 634,820 -298,900 -32.01 30,528 12.74 0.0162
2013-08-09 2013-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 933,720 933,720 27,078 0.0155
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.